Cancer chemoprevention of intestinal polyposis in ApcMin/+ mice by sulforaphane, a natural product derived from cruciferous vegetable

Carcinogenesis

Volumn 27, Issue 10, 2006, Pages 2038-2046

  Hu, Rong ^a   Khor, Tin Oo ^a   Shen, Guoxiang ^a   Jeong, Woo Sik ^a,c   Hebbar, Vidya ^a   Chen, Chi ^a   Xu, Changjiang ^a   Reddy, Bandaru ^a   Chada, Kiran ^b   Kong, Ah Ng Tony ^a  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c Inje University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BIOLOGICAL MARKER; CYCLIN D1; ISOTHIOCYANIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; SULFORAPHANE; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BROCCOLI; CAULIFLOWER; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CRUCIFERA; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM CANCER; DISEASE MODEL; DOSE RESPONSE; DRUG EFFICACY; GASTROINTESTINAL POLYPOSIS; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TREATMENT DURATION; TUMOR VOLUME; VEGETABLE;

ADENOMA; ANIMALS; ANTICARCINOGENIC AGENTS; CELL PROLIFERATION; CODON, NONSENSE; COLORECTAL NEOPLASMS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENES, APC; INTESTINAL POLYPS; MAP KINASE SIGNALING SYSTEM; MICE; THIOCYANATES;

EID: 33749581701     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl049     Document Type: Article

References (39)

1. Morin,P.J., Vogelstein,B. and Kinzler,K.W. (1996) Apoptosis and APC in colorectal tumorigenesis. Proc. Natl Acad. Sci. USA, 93, 7950-7954.
2. Yuan,P., Sun,M.H., Zhang,J.S., Zhu,X.Z. and Shi,D.R. (2001) APC and K-ras gene mutation in aberrant crypt foci of human colon. World J. Gastroenterol., 7, 352-356.
3. Tetsu,O. and McCormick,F. (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 398, 422-426.
4. He,T.C., Sparks,A.B., Rago,C., Hermeking,H., Zawel,L., da Costa,L.T., Morin,P.J., Vogelstein,B. and Kinzler,K.W. (1998) Identification of c-MYC as a target of the APC pathway. Science, 281, 1509-1512.
5. Su,L.K., Kinzler,K.W., Vogelstein,B., Preisinger,A.C., Moser,A.R., Luongo,C., Gould,K.A. and Dove,W.F. (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science, 256, 668-670.
6. Moser,A.R., Pitot,H.C. and Dove,W.F. (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science, 247, 322-324.
7. Lin,H.J., Probst-Hensch,N.M., Louie,A.D., Kau,I.H., Witte,J.S., Ingles,S.A., Frankl,H.D., Lee,E.R. and Haile,R.W. (1998) Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas. Cancer Epidemiol. Biomarkers Prev., 7, 647-652.
8. Zhang,Y., Kensler,T.W., Cho,C.G., Posner,G.H. and Talalay,P. (1994) Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc. Natl Acad. Sci. USA, 91, 3147-3150.
9. Chung,F.L., Conaway,C.C., Rao,C.V. and Reddy,B.S. (2000) Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate. Carcinogenesis, 21, 2287-2291.
10. Kassie,F., Uhl,M., Rabot,S., Grasl-Kraupp,B., Verkerk,R., Kundi,M., Chabicovsky,M., Schulte-Hermann,R. and Knasmuller,S. (2003) Chemoprevention of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-induced colonic and hepatic preneoplastic lesions in the F344 rat by cruciferous vegetables administered simultaneously with the carcinogen. Carcinogenesis, 24, 255-261.
11. Fahey,J.W., Haristoy,X., Dolan,P.M., Kensler,T.W., Scholtus,I., Stephenson,K.K., Talalay,P. and Lozniewski,A. (2002) Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc. Natl Acad. Sci. USA, 99, 7610-7615.
12. Hecht,S.S., Kenney,P.M., Wang,M. and Upadhyaya,P. (2002) Benzyl isothiocyanate: An effective inhibitor of polycyclic aromatic hydrocarbon tumorigenesis in A/J mouse lung. Cancer Lett., 187, 87-94.
13. Hulit,J., Wang,C., Li,Z. et al. (2004) Cyclin D1 genetic heterozygosity regulates colonic epithelial cell differentiation and tumor number in ApcMin mice. Mol. Cell. Biol., 24, 7598-7611.
14. Rajnakova,A., Goh,P.M., Chan,S.T., Ngoi,S.S., Alponat,A. and Moochhala,S. (1997) Expression of differential nitric oxide synthase isoforms in human normal gastric mucosa and gastric cancer tissue. Carcinogenesis, 18, 1841-1845.
15. Endo,K. and Terada,T. (2000) Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: Relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival. J. Hepatol., 32, 78-84.
16. Jackson,S.J. and Singletary,K.W. (2004) Sulforaphane: A naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization. Carcinogenesis, 25, 219-227.
17. Chiao,J.W., Chung,F.L., Kancherla,R., Ahmed,T., Mittelman,A. and Conaway,C.C. (2002) Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. Int. J. Oncol., 20, 631-636.
18. Fimognari,C., Nusse,M., Cesari,R., Iori,R., Cantelli-Forti,G. and Hrelia,P. (2002) Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane. Carcinogenesis, 23, 581-586.
19. Gamet-Payrastre,L., Li,P., Lumeau,S., Cassar,G., Dupont,M.A., Chevolleau,S., Gasc,N., Tulliez,J. and Terce,F. (2000) Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res., 60, 1426-1433.
20. Bonnesen,C., Eggleston,I.M. and Hayes,J.D. (2001) Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Res., 61, 6120-6130.
21. Hugh,T.J., Dillon,S.A., O'Dowd,G., Getty,B., Pignatelli,M., Poston,G.J. and Kinsella,A.R. (1999) Beta-catenin expression in primary and metastatic colorectal carcinoma. Int. J. Cancer, 82, 504-511.
22. Cheah,P.Y., Choo,P.H., Yao,J., Eu,K.W. and Seow-Choen,F. (2002) A survival-stratification model of human colorectal carcinomas with betacatenin and p27kip1. Cancer, 95, 2479-2486.
23. Arber,N., Hibshoosh,H., Moss,S.F., Sutter,T., Zhang,Y., Begg,M., Wang,S., Weinstein,I.B. and Holt,P.R. (1996) Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology, 110, 669-674.
24. Jeong,W.S., Kim,I.W., Hu,R. and Kong,A.N. (2004) Modulation of AP-1 by natural chemopreventive compounds in human colon HT-29 cancer cell line. Pharm. Res., 21, 649-660.
25. Wang,L., Liu,D., Ahmed,T., Chung,F.L., Conaway,C. and Chiao,J.W. (2004) Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. Int. J. Oncol., 24, 187-192.
26. Dodelet,V.C. and Pasquale,E.B. (2000) Eph receptors and ephrin ligands: embryogenesis to tumorigenesis. Oncogene, 19, 5614-5619.
27. Batlle,E., Bacani,J., Begthel,H. et al. (2005) EphB receptor activity suppresses colorectal cancer progression. Nature, 435, 1126-1130.
28. Yun,M.S., Kim,S.E., Jeon,S.H., Lee,J.S. and Choi,K.Y. (2005) Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation. J. Cell. Sci., 118, 313-322.
29. Dihlmann,S., Kloor,M., Fallsehr,C. and von Knebel Doeberitz,M. (2005) Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells. Carcinogenesis, 26, 1503-1512.
30. Licato,L.L. and Brenner,D.A. (1998) Analysis of signaling protein kinases in human colon or colorectal carcinomas. Dig. Dis. Sci., 43, 1454-1464.
31. Khor,T.O., Gul,Y.A., Ithnin,H. and Seow,H.F. (2004) Positive correlation between overexpression of phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma. Cancer Lett., 210, 139-150.
32. Moran,A.E., Hunt,D.H., Javid,S.H., Redston,M., Carothers,A.M. and Bertagnolli,M.M. (2004) Apc deficiency is associated with increased Egfr activity in the intestinal enterocytes and adenomas of C57BL/6JMin/+ mice. J. Biol. Chem., 279, 43261-43272.
33. Zhu,Y., Zhong,X., Zheng,S., Ge,Z., Du,Q. and Zhang,S. (2005) Transformation of immortalized colorectal crypt cells by microcystin involving constitutive activation of Akt and MAPK cascade. Carcinogenesis, 26, 1207-1214.
34. Andreyev,H.J., Norman,A.R., Cunningham,D., Oates,J.R. and Clarke,P.A. (1998) Kirsten ras mutations in patients with colorectal cancer: The multicenter 'RASCAL' study. J. Natl Cancer Inst., 90, 675-684.
35. Dicuonzo,G., Angeletti,S., Garcia-Foncillas,J., Brugarolas,A., Okrouzhnov,Y., Santini,D., Tonini,G., Lorino,G., De Cesaris,M. and Baldi,A. (2001) Colorectal carcinomas and PTEN/MMAC1 gene mutations. Clin. Cancer Res., 7, 4049-4053.
36. de Bono,J.S. and Rowinsky,E.K. (2002) Therapeutics targeting signal transduction for patients with colorectal carcinoma. Br. Med. Bull., 64, 227-254.
37. Myzak,M.C., Dashwood,W.M., Orner,G.A., Ho,E. and Dashwood,R.H. (2006) Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice. FASEB J., 20, 506-508.
38. Qian,D.Z., Kato,Y., Shabbeer,S., Wei,Y., Verheul,H.M., Salumbides,B., Sanni,T., Atadja,P. and Pili,R. (2006) Targeting tumor angiogenesis with histone deacetylase inhibitors: The hydroxamic acid derivative LBH589. Clin. Cancer Res., 12, 634-642.
39. Mabley,J.G., Pacher,P., Bai,P., Wallace,R., Goonesekera,S., Virag,L., Southan,G.J. and Szabo,C. (2004) Suppression of intestinal polyposis in Apcmin/+ mice by targeting the nitric oxide or poly(ADP-ribose) pathways. Mutat Res., 548, 107-116.